Medical Journals

Induction of the Adenoma-carcinoma Progression and Cdc25a-b Phosphatases by the Trefoil Factor Tff1 in Human Colon Epithelial Cells.

Authors:
  • Rodrigues S
  • Rodrigue C M
  • Attoub S
  • FlĂ©jou J F
  • Bruyneel E
  • Bracke M
  • Emami S
  • Gespach C

From: INSERM U. 673 and University of Paris VI, Molecular and Clinical Oncology of Solid tumors, Paris Cedex 12, France.

Oncogene

  • Publish Date: Oct 2006
  • ISSN: 0950-9232
  • Volume: 25
  • Issue: 50
  • Pages: 6628-36
  • Medium: Print
  • Language: English
  • Citation (JAMA): Rodrigues S, Rodrigue C M, Attoub S, et al. Induction of the Adenoma-carcinoma Progression and Cdc25a-b Phosphatases by the Trefoil Factor Tff1 in Human Colon Epithelial Cells.. Oncogene Oct 2006;25:6628-36

Abstract

TFF1 is overexpressed in inflammatory diseases and human cancers of the digestive and urogenital systems. To examine the transforming potential of TFF1 in human colon epithelial cells, premalignant PC/AA/C1 adenoma cells (PC) derived from a patient with familial adenomatous polyposis (FAP) were transformed by the TFF1 cDNA and used as a model of the adenoma-carcinoma transition. Constitutive expression of TFF1 increased anchorage-independent cell growth in soft agar, and induced or potentiated the growth of colon PC-TFF1 and kidney MDCKts.src-TFF1 tumor xenografts in athymic mice. This resulted in reduction of thapsigargin-induced apoptosis and promotion of collagen type I invasion through several oncogenic pathways. Using the differential display approach to identify TFF1 target genes, we found that the dual specific phosphatases Cdc25A and B implicated in cell cycle transitions are strongly upregulated under active forms in both PC-TFF1 and HCT8/S11-TFF1 colon cancer cells. Accordingly, TFF1 expression is absent in normal human colon crypts but is induced in correlation with Cdc25a and b transcript levels and tumor grade in familial and sporadic colon adenomas and carcinomas. We propose that TFF1 and Cdc25A-B cooperate with other dominant oncogenic pathways to induce the adenoma and adenocarcinoma transitions. Agents that target TFF1/Cdc25 signaling pathways may be useful for treating patients with TFF1-positive solid tumors.

Mesh Headings (Keywords): Adenoma, Animals, Carcinoma, Cell Adhesion, Cell Cycle Proteins, Cell Proliferation, Cell Survival, Cell Transformation, Neoplastic, Colon, Colonic Neoplasms, Colorectal Neoplasms, Disease Progression, Dogs, Enzyme Induction, Gene Expression Regulation, Neoplastic, Humans, Intestinal Mucosa, Mice, Mice, Nude, Neoplasm Invasiveness, Phenotype, Precancerous Conditions, Transfection, Transplantation, Heterologous, Tumor Cells, Cultured, Tumor Suppressor Proteins, cdc25 Phosphatases


Check for Full Text / PubMed Unique Identifier (PMID): 16715141


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.